Form 4: Astrana Health Exec Reports Stock Grant

Kenneth T. Sim, Executive Chairman of Astrana Health, Inc., reported the acquisition of 100,000 restricted stock units on April 6, 2026.

Summary

• Kenneth T. Sim, Executive Chairman and Director of Astrana Health, Inc. (ASTH), reported a transaction on April 6, 2026.
• The transaction involved the acquisition of 100,000 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of Astrana Health's common stock each.
• Vesting is scheduled to occur in eight equal semi-annual installments, commencing on October 6, 2026, contingent upon continued employment.
• The filing also details other beneficial ownerships held indirectly through various trusts and a professional medical corporation.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine executive compensation in the form of restricted stock units, rather than significant financial performance or strategic shifts.

Positives

• Grant of 100,000 restricted stock units to a key executive, indicating continued investment in leadership.
• Vesting schedule tied to continued employment, aligning executive incentives with company performance and retention.

Risks

• Vesting of RSUs is contingent upon continuous employment with Astrana Health and/or its affiliates.
• The filing notes that the reporting person disclaims beneficial ownership of securities held by entities other than directly, except to the extent of his pecuniary interest, which could imply complex ownership structures.

Future Outlook

The restricted stock units granted will vest in eight equal semi-annual installments starting October 6, 2026, provided the reporting person remains employed. Additionally, certain unvested restricted stock will vest in installments starting March 5, 2027, and April 1, 2027, also subject to continuous employment.

Industry Context

StockSavvy.ai notes that the reporting of restricted stock units is a common form of executive compensation in the healthcare technology sector, designed to incentivize long-term commitment and performance.

Stakeholder Impact

• Shareholders: The grant of RSUs to a key executive aligns their interests with long-term company performance, potentially benefiting shareholders if the executive's continued employment leads to positive outcomes.
• Employees: The vesting conditions tied to continuous employment may encourage employee retention and dedication.
• Management: Reinforces the compensation structure for executive leadership.

Next Steps

• Continued employment of Kenneth T. Sim with Astrana Health and/or its affiliates.
• Vesting of 100,000 restricted stock units in semi-annual installments starting October 6, 2026.
• Vesting of other unvested restricted stock starting March 5, 2027, and April 1, 2027.

Key Dates

Keywords

Astrana Health, ASTH, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Securities Exchange Act, SEC Filing, Beneficial Ownership